UBS O'Connor’s NEVRO CORP. NVRO Stock Holding History

UBS O'Connor’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-16,800	Closed	-$1.24M	–	511
2016 Q2	$1.24M	Buy	+16,800	New	+$1.14M	0.03%	280

Other funds holding NVRO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS O'Connor's NVRO Position: Q3 2016 in Review

UBS O'Connor sold out of NEVRO CORP. (NVRO) in Q3 2016, closing a stake of 16,800 shares — an estimated $1.24M sold.

UBS O'Connor first reported a position in NVRO in Q2 2016 and held it in 1 quarter. The position peaked at $1.24M in Q2 2016. 192 funds tracked by Wall St. Rank hold NVRO as of Q3 2016.

UBS O'Connor reported no remaining NEVRO CORP. position as of Q3 2016 after selling out during the quarter.
UBS O'Connor sold 16,800 NEVRO CORP. shares in Q3 2016, an estimated $1.24M.
UBS O'Connor first reported a position in NEVRO CORP. in Q2 2016 and held it in 1 quarter.
UBS O'Connor's NEVRO CORP. position peaked at $1.24M in Q2 2016.
192 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2016.

Based on UBS O'Connor's 13F filing for Q3 2016, filed 14 Nov 2016.